Key Highlights

  • BWX Technologies (NYSE:BWXT) settled at USD 118.82 on November 17, rising 1.48% and trading roughly 5.6% over its 52-week bottom.
  • Third quarter sales increased 10% to USD 953.0 million, failing to reach estimates near USD 970 million, whereas adjusted EPS of USD 1.26 cleared expectations near USD 1.18.
  • Adjusted EBITDA rose 19% to USD 179.7 million, and 2026 Revenue expectations remain near USD 3.8 billion while other targets were narrowed.
  • Overall Backlog touched roughly USD 8.6 billion, up near 16%, though the stock has shed close to 40% across six months.

Earnings Ahead of Expectations, Sales Behind

The nuclear components and fuel firm published third quarter numbers on November 2. Sales of USD 953.0 million grew 10%, with Government Operations rising 4% to USD 639.1 million and Commercial Operations jumping 25% to USD 314.2 million, the latter aided by Kinectrics and a recent purchase. Operating Income in the Government segment advanced 26% to USD 122.6 million thanks to better efficiency in naval nuclear programs. Adjusted EPS of USD 1.26 gained 26%, and adjusted EBITDA of USD 179.7 million rose 19%. Operating Cash Flow grew 42% to USD 202.7 million and free cash flow climbed 59% to USD 150.5 million. The sales gap versus estimates was roughly 1.8%, and the pace of new orders unsettled traders, pushing shares down about 2% to 2.7% after hours that day. Government bookings trailed the prior year, when a very large award had been booked, a point drawn from the release's backlog tables. Adjusted EBITDA margins were approximately 22.6% in government and 13.2% in commercial activities.

Reasons the Shares Are Near Their Floor

BWXT has declined roughly 40% in six months from a 52-week peak near USD 242, and at report time the stock was trading beneath the lower boundary of its band. A reset in valuation accounts for much of the slide, because the shares had carried a rich multiple built on anticipation of a nuclear order surge. Investors are seeking firm reactor commitments, and management now expects large reactor plant orders by late 2026 and no later than the first half of 2027. Any capacity spending in Poland would hinge on firm orders, management stated, which moderates hopes for growth in the near term. Higher yields, with the 10 year Treasury near 5.1%, have pressured long duration growth equities, and industrial names retreated on November 17. Elevated fuel and Capital costs make investors cautious, and a 2027 pension contribution of roughly USD 10 million adds a small burden. Management also noted that a fresh multi year naval fuel pricing deal is being negotiated, a contract worth tracking closely.

Potential Paths to a Rebound

The company tightened 2026 targets to adjusted EBITDA near USD 667 million, adjusted EPS between USD 4.72 and USD 4.77, and free cash flow of USD 350 million to USD 360 million. The early 2027 view anticipates high single digit revenue expansion and high single to low double digit improvement in adjusted EBITDA and EPS. Construction is underway on a depleted uranium plant in Tennessee tied to a USD 1.6 billion contract, an enrichment plant is being designed, and a prototype centrifuge is expected to be tested by year end 2026. The microreactor concept was chosen for an Army initiative spanning over 20 reactors across five bases and for a New Brunswick, Canada project. Fitch granted its first Investment grade rating. Clear large reactor orders, a Canadian plant award or robust fourth quarter bookings would be the most direct rebound signals. Chief executive Rex Geveden framed the cycle as spanning several decades. The company also aims for 2030 revenue between USD 5.5 billion and USD 6.0 billion.

Where Things Stand

BWX Technologies keeps growing Earnings and backlog, but a revenue shortfall, softer bookings and a reset valuation have left shares close to their 52-week floor. Canadian investors can track the New Brunswick microreactor project as a local reference, while firm reactor orders remain the principal catalyst.